Clinical Findings and Related Factors with the Final Outcome in Hospitalized COVID-19 Patients: An Evidence Based Cross-sectional Study
Abstract
Background: Numerous conventional laboratory diagnostic tests has been developed to diagnose COVID-19 infection. These include but are not limited to measurement of the antibody titer against the viruses, screening the viral antigen and RT-PCR from samples obtained from nasopharynx swaps, sputum, the secretions of the lower respiratory tract, blood, and feces. Infection with SARS-CoV-2 could manifest as nonspecific symptoms such as fatigue, muscle sore, fever, and nonproductive coughs. Recent studies suggest that blood group type might play a role in determining prognosis in COVID-19 patients. Opting for the suitable diagnostic tests is essential in the timely management of these patients. In our study, we aimed at the comparison of distribution patterns of COVID 2019 and estimation of the partial frequency of the clinical findings of COVID 2019 in order to facilitate decision making of the physicians and differentiating the factors having impact on the final outcome of the hospitalized patients
Methods: In a cross-sectional descriptive-analytic study, a total of 350 patients diagnosed with COVID-19 were enrolled. The information on the previous encounters, clinical signs on admission and at the hospitalizations time, and lab results on admission were collected. Radiological findings such as chest X-ray were also collected. The questionnaires were filled out by experienced staff.
Results: A total of 350 patients with the median age of 64 years old, 204 (58.3%) male and 146 (41.7%) female were studied. 110 people (31.4%) were hospitalized in ICU. The most common underlying diseases were hypertension, diabetes, cardiac diseases, renal diseases, and cancer. Blood group types A+ and O+ were the most common blood group types among the ICU hospitalized patients P <0.0001. There was a statistically significant correlation between blood group type and mortality among the studies patients. The highest rate of the mortality was amongst patients with blood group type A+ and O+ P <0.0001.
Conclusion: Fever, fatigue and non-productive coughs, dyspnea, leukopenia, leukocytosis, lymphopenia, thrombocytopenia, thrombocytosis, increased ESR, increased CRP, and increased D-dimer are the most common clinical and laboratory findings in COVID-19 patients. A statistically significant correlation was observed between the patients hospitalized in ICU and the blood group type; the most frequent blood group type was A+ followed by O+.
[2] Soleimanpour H, Sarbazi E, Esmaeili ED, Mehri A, Fam SG, Nikbakht HA, Saadati M, Sedighi S, Vali M, Azizi H. Predictors of receiving COVID-19 vaccine among adult population in Iran: an observational study. BMC Public Health. 2023;23(1):490.
[3] Bagi HM, Soleimanpour M, Abdollahi F, Soleimanpour H. Evaluation of clinical outcomes of patients with mild symptoms of coronavirus disease 2019 (COVID-19) discharged from the emergency department. PloS one. 2021;16(10):e0258697.
[4] Shahsavarinia K, Ghojazadeh M, Ghabousian A, Hatefnia F, Soleimanpour M, Soleimanpour H. An umbrella review of clinical efficacy and adverse cardiac events associated with hydroxychloroquine or chloroquine with or without azithromycin in patients with COVID-19. Anesth Pain Med. 2021;11(4).
[5] Shadvar K, Tagizadiyeh A, Gamari AA, Soleimanpour H, Mahmoodpoor A. Hemoperfusion as a potential treatment for critically ill COVID-19 patients with cytokine storm. Blood Purif. 2021;50(3):405-7.
[6] Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P. A novel coronavirus from patients with pneumonia in China, 2019. New England J Med. 2020;382(8):727-33.
[7] Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DS, Du B. Clinical characteristics of coronavirus disease 2019 in China. New England J Med. 2020;382(18):1708-20.
[8] Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet. 2020;395(10229):1054-62.
[9] Sun P, Qie S, Liu Z, Ren J, Xi J. Clinical characteristics of 50404 patients with 2019-nCoV infection. MedRxiv. 2020:2020-02.
[10] Zu ZY, Jiang MD, Xu PP, Chen W, Ni QQ, Lu GM, Zhang LJ. Coronavirus disease 2019 (COVID-19): a perspective from China. J Radiol. 2020;296(2):E15-25.
[11] Zhao J, Yang Y, Huang H, Li D, Gu D, Lu X, Zhang Z, Liu L, Liu T, Liu Y, He Y. Relationship between the ABO blood group and the coronavirus disease 2019 (COVID-19) susceptibility. Clin Infect Dis. 2021;73(2):328-31.
[12] Zhan Y. ABO blood type and ARDS. Chest. 2015;147(2):e67.
[13] Deschasaux-Tanguy M, Szabo de Edelenyi F, Druesne-Pecollo N, Esseddik Y, Allègre J, Srour B, Galan P, Hercberg S, Severi G, Zins M, Wiernik E. ABO blood types and SARS-CoV-2 infection assessed using seroprevalence data in a large population-based sample: the SAPRIS-SERO multi-cohort study. Scientific Reports. 2023;13(1):4775.
[14] Ijaz S, Cheema AH, Rafiq A, Asghar A, Shah Syed AR, Syed AA, Eqbal F, Mumtaz H. Relationship between the ABO blood group and Rhesus factors with COVID-19 susceptibility. Expert Rev Hematol. 2023;16(4):297-303.
[15] Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.
[16] Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DS, Du B. Clinical characteristics of 2019 novel coronavirus infection in China. MedRxiv. 2020.
[17] Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Yu T. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13.
[18] Ozcan E, Yavuzer S, Borku Uysal B, Islamoglu MS, Ikitimur H, Unal OF, Akpinar YE, Seyhan S, Koc S, Yavuzer H, Cengiz M. The relationship between positivity for COVID-19 RT-PCR and symptoms, clinical findings, and mortality in Turkey. Expert Rev Mol Diagn. 2021;21(2):245-50.
[19] Jaillon S, Berthenet K, Garlanda C. Sexual dimorphism in innate immunity. Clin Rev Allergy Immunol. 2019; 56:308-21.
[20] Libert C, Dejager L, Pinheiro I. The X chromosome in immune functions: when a chromosome makes the difference. Nat Rev Immunol. 2010;10(8):594-604.
[21] Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62.
[22] Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International J Antimicrob Agents. 2020;55(3):105924.
[23] Nasrollahzadeh Sabet M, Khanalipour M, Gholami M, Sarli A, Rahimi Khorrami A, Esmaeilzadeh E. Prevalence, clinical manifestation and mortality rate in COVID-19 patients with underlying diseases. J Arak Uni Med Sci. 2020;23(5):740-9.
[24] Akhavizadegan H, Aghaziarati M, Roshanfekr Balalemi MG, Arman Broujeni Z, Taghizadeh F, Akbarzadeh Arab I, Janani M. Relationship between comorbidity, chronic diseases, ICU hospitalization, and death rate in the elderly with Coronavirus infection. Iran J Ageing. 2021;16(1):86-101.
[25] Mohammadi M, Amini Nasab Z, Bajdi Gezik F, Lashkari R, Rastin T, A review of the effect of coronary heart disease on the care of hypertensive patients in South Khorasan, the second national conference on new biological findings, Zahedan. 2020.
[26] Talebi S, Nematshahi M, Tajabadi A, Khosrogerdi A. Comparison of clinical and epidemiological characteristics of deceased and recovered patients with COVID-19 in Sabzevar, Iran. J Mil Med 2022;22(6):509-16.
Files | ||
Issue | Article in Press | |
Section | Research Article(s) | |
Keywords | ||
COVID-19 blood group type mortality Evidence Based Medicine |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |